3701-83-23.4 Infection control and prevention.

 

 

 

3701-83-23.4               Infection control and prevention.

 

 

 

(A)   In addition to the requirements established in rules 3701-83-09 and 3701-83-23.1 of the Administrative Code, each dialysis center shall develop and follow written policies and procedures for preventing and controlling infections. The policies and procedures shall include, but are not limited to, the following:

 

(1)   The aseptic and isolation techniques to be used;

 

(2)   Use of the isolation room where applicable;

 

(3)   Handling and disposal of biohazardous and potentially infectious waste;

 

(4)   Cleaning and maintenance of equipment;

 

(5)   Cleaning and disinfection of surfaces; and

 

(6)   Use of universal standard precautions and personal protective equipment.

 

(B)   Each dialysis center shall establish and follow a preventive maintenance program that includes periodic calibration, cleaning and adjustment of all equipment in accordance with manufacturer's instructions.

 

(C)     In addition to the water requirements established in rule 3701-83-23.1 of the Administrative Code, each dialysis center shall:

 

(1)   Culture and conduct water specimen analysis used for dialysis purposes at least every thirty days for bacteria;

 

(2)   Analyze water used for dialysis purposes at least every one hundred and eighty days for chemicals;

 

(3)     Treat  water  as  necessary  to  maintain  a  continuous  water  supply  that  is biologically and chemically compatible with acceptable dialysis techniques.

 

(D)    Each dialysis center shall conduct routine surveillance of patients and staff for hepatitis B using the most sensitive test methods available. Patients and new employees must be screened for hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) before or at the time they enter the unit in order to determine their serologic status for surveillance purposes. Each dialysis center shall offer the hepatitis B vaccine to staff and document such action in the staff member's personnel record.

 

 

(1) Each patient must be screened for hepatitis B surface antigen (HBsAG) and hepatitis B surface antibody before admission to the dialysis facility in order to determine their serologic status for surveillance purposes;

(2) New employees must be screened for hepatitis B surface antigen (HBsAG) and hepatitis B surface antibody before or at the time of hire in order to determine their serologic status for surveillance purposes; and

(3) Each dialysis center shall offer the hepatitis B vaccine to all susceptible patients and all staff and document such action in the patient's medical record or the staff member's personnel record.

(E)   Each dialysis facility shall investigate and report to the director incidents of infections associated with the provision of dialysis services. Efforts shall be made to determine the origin of any such infection and remedial action shall be taken to protect all non-infected patients and prevent recurrence.

(F)   Each dialysis facility shall comply with the reporting requirements established by rule 3701-3-03 and paragraph (A)(10) of rule 3701-83-23.1 of the Administrative Code.

Effective:   R.C. 119.032 review dates:	04/24/2011   02/07/2011 and 02/10/2016
CERTIFIED ELECTRONICALLY
Certification
04/14/2011
Date
Promulgated Under:	119.03
Statutory Authority:	3702.13, 3702.30
Rule Amplifies:	3702.12, 3702.13, 3702.30
Prior Effective Dates:	9/5/2002, 6/29/09